EDUARDO LUIS ANGUITA MANDLY-rekin lankidetzan egindako argitalpenak (3)

2024

  1. Economic impact of immunoglobulin replacement therapy in secondary immunodeficiency to hematological cancer: a single center observational study

    Frontiers in Immunology, Vol. 15

2023

  1. Specific Cellular and Humoral Immune Responses to the Neoantigen RBD of SARS-CoV-2 in Patients with Primary and Secondary Immunodeficiency and Healthy Donors

    Biomedicines, Vol. 11, Núm. 4

2022

  1. Combined Immune Defect in B-Cell Lymphoproliferative Disorders Is Associated with Severe Infection and Cancer Progression

    Biomedicines, Vol. 10, Núm. 8